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KAJIAN IN VITRO DAN IN SILICO KEATAS TUMBUHAN MASAKAN 
MALAYSIA TERPILIH TERHADAP PROTEASE DENGGI NS2B-NS3 
 
ABSTRAK 
 
Di Malaysia, statistik jangkitan denggi setakat tahun 2015 sudah melebihi 100,000 
kes. Walaubagaimanapun sehingga kini tidak ada calon vaksin dan ubat untuk denggi yang 
boleh didapati di pasaran. Oleh itu, penemuan ubat untuk denggi adalah penting untuk 
mencari calon ubat yang sesuai. Kajian ini melibatkan pencirian kimia juzuk, eksperimen in 
vitro dan simulasi in silico untuk tumbuh-tumbuhan yang digunakan dalam masakan harian 
di Malaysia. Dalam kajian ini, kunyit, serai wangi, daun kari, daun selasih, daun pandan, 
daun kesum dan halia dipilih dalam saringan bioaktiviti terhadap NS2B-NS3 protease. 
Tumbuh-tumbuhan tempatan ini dipilih sebab mereka memaparkan keputusan yang menarik 
dalam penyaringan maya pada kajian yang lepas. Antara tujuh tumbuhan, daun kesum dan 
daun kari didapati sangat aktif dalam merencat denggi NS2B-NS3 protease dengan 93% dan 
88% perencatan masing-masing. F2_1 (IC50 17.4 μM) diasingkan dari daun kesum 
menyerupai Vanicoside A mempunyai perencatan yang lebih baik daripada rujukan 
Panduratin A (IC50 94.60 μM) manakala Bismahanine (IC50 93.1 μM) diasingkan dari daun 
kari mempunyai perencatan yang serupa dengan Panduratin A. Dari hasil pendokan, sebatian 
F2_1 mempunyai interaksi polar dengan amino asid pada struktur krystal 3U1I manakala 
Bismahanine mempunyai interaksi ikatan hydrogen dengan triad pemangkin (His51, Asp75, 
Ser135) yang lebih baik daripada enzim protease. Walau bagaimanapun, F2_1 dan 
Bismahanine cenderung untuk beragregat pada kepekatan mikro molar dan IC50 masing-
masing 319.4 μM dan 327.3 μM dalam asai berasaskan detergen. Kajian masa depan boleh 
dilakukan pada pengubahsuaian kimia pada struktur Bismahanine bagi merekabentuk 
perencat denggi NS2B-NS3 yang lebih baik.  
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IN VITRO AND IN SILICO STUDIES ON SELECTED MALAYSIA CULINARY 
PLANTS AGAINST DENGUE NS2B-NS3 PROTEASE 
 
ABSTRACT 
 
In Malaysia, dengue infection was reported more than 100,000 cases in year 2015. 
To date there is no marketed drug candidate available for Dengue disease. Therefore, drug 
discovery for dengue is important to find a suitable drug candidate. This study involves 
characterization of chemical constituent, in vitro experiment and in silico simulation for anti-
dengue from culinary plants in Malaysia. In this study, turmeric, lemon grass, curry leaves, 
sweet basil, screw pine, Vietnamese mint and ginger were screened for bioactivity against 
dengue NS2B-NS3 protease. The rational of choosing these native culinary plants because 
they show interesting result in virtual screening in previous study. Out of seven plants, 
Vietnamese mint and curry leaves were found highly active in inhibiting dengue NS2B-NS3 
protease with 93% and 88% inhibition, respectively. Compound F2_1 (IC50 of 17.4 μM) 
isolated from Vietnamese mint which is similar to be Vanicoside A showed better inhibition 
than reference Panduratin A (IC50 of 94.60μM) while Bismahanine (IC50 of 93.1 μM) 
isolated form curry leaves has similar inhibition activity with Panduratin A. From docking 
result, compound F2_1 formed polar interaction with amino acid residues of protease crystal 
structure, 3U1I while Bismahanine has hydrogen bond interactions with the catalytic triad 
(His51, Asp75, Ser135) of protease which is more preferable. However, F2_1 and 
Bismahanine tend to aggregate at micromolar concentration and the IC50 increased to 319.4 
μM and 327.3 μM respectively in the detergent-based assay. Future studies especially on the 
chemical modification of the structure of Bismahanine could be carried out in order to 
discover more potent dengue protease inhibitors.  
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CHAPTER ONE 
INTRODUCTION 
 
1.1 Statement of Problem 
Dengue disease, an arthropod-borne viral infection, has affected more than 100 
countries worldwide. Every year, nearly 390 million cases of this infection are reported and 
over 3.9 billion people are at risk (Bhatt et al., 2013). There is an increasing trend of dengue 
cases due to climate change, flourishing of tourism industry (Freedman et al., 2006), 
unorganized urbanization and poor water management system. In Malaysia, it is an endemic 
and epidemic disease which increases yearly. In the year 2013, 43,346 cases reported and 
this number increased drastically to 103,610 cases in 2014 (WHO, 2014) and 107,079 cases 
in the year 2015 (WHO, 2015).  
 
To date, there is no efficient marketed drug to treat dengue. Lack of suitable animal 
model (Zompi & Harris, 2012) for in vivo study slow down the dengue drug discovery 
compounded with the fact that part of the mechanisms of dengue virus infection is still 
unclear (Thullier et al., 2001).  
 
Only few peptides (Yin et al., 2006), non-peptide (Ganesh et al., 2005), small 
molecules (Deng et al., 2012) and natural compounds (de Sousa et al., 2015) have been 
reported to have inhibition activity towards dengue NS2B-NS3 protease. For instance, 
aprotinin inhibits dengue virus activity at submicromolar concentrations. However it cannot 
be developed as drug due to its large unstable peptide structure that would envelops enzyme 
and blocks substrate from approaching the active site and form non-competitive inhibition 
(Leung et al., 2001). Ribavirin, a RNA virus inhibitor, suppresses virus replication in vitro 
but shows protective effect in animal study (Leyssen et al., 2008). Kalata B1 cyclotide, one 
type of plant protein, which is designed and synthesized from natural cyclotide has potent 
inhibition from dengue NS2B-NS3 protease (Gao et al., 2010). The findings of cyclohexenyl 
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chalcone derivatives isolated from Bosenbergia rotunda as competitive inhibitors to DEN2 
NS2B-NS3 protease (Kiat et al., 2006) have encouraged researchers to find more potential 
drugs from natural product.  
 
Natural product has been established as excellent lead for therapeutic field, for 
example, taxol from Taxus brevifolia that treats cancer and artemisinin from Artemisia 
annua is widely used in treating malaria (Phillipson, 2001). Vinblastine from Catharanthus 
roseus (L.) is a vinca alkaloid and chemical analogue of vincristine. Both compounds are 
chemotherapy medication used to treat acute lymphocytic leukemia, acute myeloid leukemia, 
Hodgkin's disease, neuroblastoma, and small cell lung cancer (Lahlou, 2013).  
 
Interestingly, the endemic cases of dengue usually occur in developing or 
underdeveloped countries with inadequate facilities where most patients could not afford 
expensive treatment. Drug discovery and development of dengue disease should not 
contribute to high-priced medicines that burden the patients. Therefore exploration of plant 
compounds is suitable as they are natural and cheap sources for remedy. Malaysia is rich in 
flora and fauna with over 16,000 flowering plants (Napis et al., 2001) and 3000 species of 
medicinal plants, providing broad environment and good opportunity to drug discovery and 
development for dengue disease.  
 
In addition, computational method has an apparent important role in drug discovery 
and development from the stage of target identification, lead discovery, and lead 
optimization, preclinical to clinical trials since 1980s (Ou Yang et al., 2012). In silico 
methods decrease the amount of resources required for trial experiment, simulate the 
working environment and predict chemical interaction, and therefore aid in improving 
efficacy and efficiency of drug discovery (Kapetanovic, 2008).  
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Some commercial drugs begin their research with computer aided drug design 
method. Captopril is the first success drug candidate using structure based drug design. It is 
an angiotensin-converting enzyme (ACE) inhibitor used for hypertension and treat 
congestive heart failure (Cushman et al., 1977). Dorzolamide is carbonic anhydrase inhibitor 
use in the treatment of the ocular disease, glaucoma (Greer et al., 1994). Nelfinavir is HIV 
protease inhibitor (Wlodawer & Vondrasek, 1998). Zanamivir demonstrate the power of 
rational, structure-based and computer assisted drug design. It is neuraminidase inhibitor 
received US FDA approval in 1999 for the treatment of the influenza A and B viruses. (von 
Itzstein et al., 1993). Imatinib is tyrosine kinase inhibitor for bcr-abl fusion protein 
(Philadelphia chromosome-positive leukemias) with the help of rational drug design 
approach (Nagar et al., 2002).  
 
In this study, the main aim was to utilise local natural product as the sources of 
candidate for dengue inhibitors confirmed by the in vitro enzymatic assay. The mechanism 
of action of inhibitor will then be investigated thoroughly using in silico molecular docking 
study.  
 
1.2 Objectives and Scopes of Research 
This study involved the screening of the inhibitory activity of selected Malaysian 
culinary plants using in vitro dengue enzyme bioassay. Seven plants were selected for 
extraction, separation and characterisation of the natural products. Each extract’s fraction 
was evaluated in dengue enzymatic bioassay system and the active fraction was further sub-
fractionated or isolated. Structure elucidation of chemical constituent was carried out with 
High Performance Liquid Chromatography (HPLC), Fourier Transform Infrared 
Spectroscopy (FTIR), Quadrupole Time-of-flight Mass Spectrometry (QTof-MS) and 
Nuclear Magnetic Resonance (NMR). Bioactivity of chemical constituent was evaluated 
using dengue enzymatic bioassay. Molecular interaction between chemical constituent and 
protein structure was studied with in silico method using software Autodock 4.2.  
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Specifically, the objectives of this study are: 
1. To determine the inhibition activity of fractions from Malaysian culinary plants 
towards dengue protease NS2B-NS3 using in vitro method. 
2. To characterise chemical constituents from Malaysian culinary plants with potential 
anti dengue property. 
3. To study the interaction between chemical constituent and dengue protease using in 
silico docking method. 
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2.3 Natural Product in Drug Discovery 
Plants are used as medicine by folks since ancient time (Weldegerima, 2009). 
Traditionally, plants with fewer side effects are the major driver in the study of 
phytochemical of natural products (Phillipson, 2001). Sources of natural products however 
are not only limited to higher plant species but also include terrestrial plants, microorganisms, 
marine organisms, vertebrates and invertebrates. The traditional way of drug discovery 
involving natural product is a high cost and time consuming. Thus, in modern days, different 
kinds of strategies such as genetic engineering, high speed dereplication and advanced 
methods in separation are used to expand the usage of natural products in drug discovery 
(Harvey, 2000). Among the families of secondary metabolites, nitrogen containing alkaloids 
are the largest group of drug (Raskin et al., 2002) while terpenoids make important 
contribution as well (Cragg, 1998).  
 
Drug discovery nowadays encompasses multidisciplinary approach from natural 
product research, combinatorial synthetic chemistry to biosynthetic pathways research and 
proteomics or genomics research. Drug discovery has shifted from natural product to 
microorganism field when the first antibiotic penicillin was derived from fungi at 1920’s. 
Natural products derived from microbes are the outcome of genes or non-ribosomal peptide 
synthetases or pathways (Baker et al., 2007). Antibiotics such as erythromycin, 
chloramphenicol and streptomycin isolated from various microbes are still being used as 
drugs today. Over sixty percent of drug in the market today have history related to natural 
product or natural product inspired. Among the 175 small molecules discovered in cancer 
research between 1940s and 2010, 48.6% are natural products or their derivatives. This 
proves the effectiveness of natural product in treating diseases and nature is shown to have 
important role in providing new scaffold for diseases (Newman & Cragg, 2012).  
 
Big pharmaceutical companies emphasize the research focusing on synthetic 
chemistry, combinatorial chemistry and genomics over the past decades. Synthetic chemistry 
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and combinatorial chemistry have been at the forefront of the development of drug discovery 
for decades but there are limitations. Synthetic drug discovery output lacked new lead 
compounds from its library as the time passed by (Lee & Schneider, 2001). Combinatorial 
chemistry research is the combination of all possible chemical building blocks but the 
outcome of the huge library of compounds brings unfruitful effect. Sorafenib from Bayer as 
anti-tumor compound is the only new chemical entity as the product of combinatorial 
chemistry research (Newman & Cragg, 2007).  Bioassay-guided extraction, separation and 
isolation with various types of chromatography technology are widely used nowadays 
(Sticher, 2008). A successful example for bioassay guided isolation method is the discovery 
of novel HIV inhibitor betulinic acid and derivatives (Itokawa et al., 2008).  
 
Discovery of new drug scaffold and pharmacophore from natural product offer new 
opportunity in the isolation of new bioactive compounds for lead discovery. So far, plants 
are still the majority sources for licensed drugs. For example, immunosuppressive agent such 
as cyclosporine A, antitumor agents such as paclitaxel and topotecan, anti-cholesterolemic 
agents such as lovastatin are derived from natural products (Bindseil et al., 2001). Aspirin, 
morphine, quinine, paclitaxel and artemisinin are also the examples of drug developed from 
natural products (Cragg et al., 1997).  
 
On the other hand, the disadvantage of natural product is the difficulties for 
resupplying the same species of plant. The isolated compounds might be in small quantities 
or are not enough for study of lead optimization, lead development and clinical trials. 
However, many plant derived drugs cannot be fully synthesized due to its complexity and 
high cost such as atropine and reserpine. Thus, natural product drug discovery need 
collaboration from fields of natural product chemistry, pharmacognosy, pharmacology, 
ethnobotany and life sciences to get a novel marketed drug for future enhancement.  
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2.4 Malaysia Culinary Plant 
Malaysia, located in the tropical area has rainforests which consist of 15,000 species 
of higher plants. According to literature review, Cymbopogon citratus (Cavalcanti et al., 
2004), Curcuma longa (Kalaivani et al., 2012), Ocimum basilicum (Murugan et al., 2007), 
Pandanus amaryllifolius (Pratama et al., 2009), Zingiber officinale (Kalaivani et al., 2012) 
and Murraya koenigii (Kovendan et al., 2012) have potential inhibition activity towards 
larvicidal activity against Aedes aegypti. Previously, in a virtual screening study in our lab, 
some of these edible plants were found to have good inhibitions towards the dengue protease 
(PhDs, unpublished result).  
 
Scientists have discovered that some Malaysian culinary plants were able to give 
promising vector control activity as shown in Table 2.2. Leave extracts of Pandanus 
amaryllifolius killed 100% of mosquito larvae of Aedes aegypti at 0.9% concentration 
(Pratama et al., 2009). Leaf extracts of Murraya koenigii had larvicidal property against 
house-resting mosquitoes in the tropical country (Kovendan et al., 2012). LC50 value of 
Ocimum basilicum was 3.7 for larvae first instar, 4.1 for second instar, 4.6 for third instar 
and 5.1 for fourth instar suggesting that the plant can be used to control larvicidal activity for 
A. aegypti. Essential oil of C. citratus is also a promising larvicide against mosquitoes 
(Cavalcanti et al., 2004), while the essential oil of Z. officinale and C. longa caused larval 
mortality within 24 hour at concentrations of 50.78 ppm and 192 ppm respectively 
(Kalaivani et al., 2012). Only P. odorata did not have any literature review regarding its 
larvicidal activity. Thus, it would be interesting for these plants to be further investigated for 
anti dengue properties in enzymatic level.  
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Table 2.2 The Selected Malaysia Culinary Plants and Their Scientific Names 
Scientific Name Common 
Name 
Malay  
Name 
Extract LC50 
(ppm) 
Reference 
Curcuma longa Turmeric Kunyit Oil  115.6  (Kalaivani et 
al., 2012) 
 
Cymbopogon 
citratus 
Lemon grass Serai Oil  69  (Cavalcanti et 
al., 2004) 
 
Murraya koenigii Curry leaves Daun kari Hex  963.53  (Kovendan et 
al., 2012) 
 
Ocimum basilicum Sweet basil Daun selasih Oil  148.5  (Kalaivani et 
al., 2012) 
 
Pandanus 
amaryllifolius 
Screw pine Daun pandan CHCl3  221.67  (Mardiyah & 
Satoto, 2014) 
 
Persicaria odorata Vietnamese 
mint 
Daun kesum -  -  - 
 
 
Zingiber officinale Ginger Halia Oil  40.5  (Kalaivani et 
al., 2012) 
 
2.4.1 Curcuma longa   
In Chinese and Indian traditional medicines, Curcuma longa is used for the 
treatment of abdominal pains, sprains and swelling as well as stomach tonic and blood 
purifier. The common name for C. longa is turmeric and it is widely used as spice in food 
preparation. Table 2.3 shows the taxonomy of this plant. 
 
Table 2.3 Taxonomy of Curcuma longa 
Rank Scientific Name Common Name 
Kingdom Plantae Plant 
Subkingdom Tracheobionta Vascular plant 
Superdivision Spermatophyta Seed plant 
Division Magnoliophyta Flowering plant 
Class Liliopsida Monocotyledons 
Order Zingiberales - 
Family Zingiberaceae Ginger family 
Genus Curcuma L. - 
Species Curcuma longa L. Turmeric 
 
The yellow pigment curcumin (diferuloylmethane) shows in Figure 2.7a is the major 
chemical constituent extracted from the rhizome of the plant. Essential oil extracted from 
rhizome contains borneol (0.5%), sabiene (0.6%), α-phellanderene (1%), cineol (1%), 
zingiberene (25%) and sesquiterpines (53%) (Jayaprakasha et al., 2005). Ar-turmerone 
